WORLD HOSPITAL DIRECTORY
Pharmaceuticals Medical FT.com Drugs and Healthcare

  Back to "Medical Updates - Homepage"


FT.com Drugs and Healthcare - Recent Medical Updates

Zealand Pharma says obesity drug deal with Roche will help it stay independent
Danish biotech is developing petrelintide in partnership with the Swiss pharma group


Insurance plans help boost growth in the healthcare industry
Companies are keen to offer employees benefits such as fertility treatment and mental health support


Tech, healthcare and energy drive corporate growth
ABA Centers tops the FT’s sixth annual ranking, compiled with Statista, of the region’s most rapidly growing companies


Trump tariffs choke vital medical device supply chain
Industry warns that trade disruption will raise prices for hospitals


The cost of Trump’s attack on American science
Sweeping funding cuts threaten to undermine the innovation that has been a central part of US economic strength for decades


‘Medical misogyny’: UK waiting list for endometriosis diagnosis hits nine years
Delays to treatment of common women’s health condition criticised by doctors and sufferers


Pharma bosses call for higher drug prices in EU to counter tariff threat
Novartis and Sanofi CEOs push for European benchmark against US prices


Roche to spend $50bn on US manufacturing and R&D
Swiss group becomes latest pharmaceutical company to promise investment in the face of potential tariffs


US patients lose access to cheaper weight-loss drugs as market for replicas winds down
Pharmacies told to stop making custom versions of Wegovy and Zepbound after shortages declared officially over


Vaccine alliance stresses commercial benefits for US in plea for funds
Gavi says continued support would help American industry as well as save over 1mn lives


US tariffs on pharmaceuticals risk shortages of lower-cost generic drugs
Vast majority of drugs prescribed in America are off-patent generics made in lower-cost countries


The race to turn brainwaves into fluent speech
Californian researchers and groups such as Precision Neuroscience use implants and AI to make advances in ‘voice prosthesis’


Trump tariffs bring furrowed brows to Ireland’s Botox town
Westport makes the world’s entire supply of the anti-wrinkle drug — now it fears production could move to the US


Fund for struggling biotechs takes aim at ‘tragedy’ for shareholders
Alis Biosciences then plans to list and offer big investors an easy way to spread their bets


Eli Lilly’s new obesity pill lowers blood sugar and aids weight loss
Promising late-stage trial results lift US pharmaceutical group’s shares almost 15%


Trump pledges to cut drug prices for Americans
Latest executive order could shake up US pharma industry


J&J warns pharma tariffs could cause drug shortages
Medical devices like group’s surgical robots have already been hit by the new US charges


Pfizer to halt development of closely watched weight-loss drug
US pharmaceutical group says patient in study experienced ‘potential drug-induced liver injury’


How policies in Ireland and Chile hit disabled people’s job prospects
The European nation has one of the largest employment gaps among OECD members and compares poorly against the South American country


Progress on disability employment is at risk under Trump policies
The US administration seeks to dismantle DEI programmes that provide customised equipment and infrastructure at work


Rosie Jones: ‘I was a disabled person who didn’t know the meaning of ableism’
At 21 and fresh out of university, I was grateful to have a job. Even now, discrimination of people with disabilities remains


AI-powered bionic limbs come at too high a cost for many
Amputees, among the largest minority at work, highlight the need for assistive technology to be affordable and accessible


NHS signs deal with Scancell in ambitious skin cancer trial
Move comes as government seeks to boost UK’s standing as drugs research leader


England’s busiest A&E department grapples with soaring demand for elderly care
A Leicester hospital is trialling a fresh approach to caring for older patients as demographic shifts loom


Trade war could put the frown back on Botox users’ faces
Fears that pharmaceuticals could yet be hit by tariffs have sent shares sharply lower